GB150334A - Manufacture of specific vaccines - Google Patents

Manufacture of specific vaccines

Info

Publication number
GB150334A
GB150334A GB24351/20A GB2435120A GB150334A GB 150334 A GB150334 A GB 150334A GB 24351/20 A GB24351/20 A GB 24351/20A GB 2435120 A GB2435120 A GB 2435120A GB 150334 A GB150334 A GB 150334A
Authority
GB
United Kingdom
Prior art keywords
bacteria
separated
added
addition
colloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24351/20A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELEKTRO OSMOSE AG
Original Assignee
ELEKTRO OSMOSE AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELEKTRO OSMOSE AG filed Critical ELEKTRO OSMOSE AG
Publication of GB150334A publication Critical patent/GB150334A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

150,334. Elektro-Osmose Akt.-Ges., (Graf Schwerin Ges.). Aug. 23, 1919, [Convention date]. Addition to 150,328. Vaccines and immunizing serums.-Specific vaccines prepared by the action of an electric current on suspensions of bacteria as described in the parent Specification are stabilized by the addition of a. protective colloid. The added colloid may be derived from immune blood serum corresponding to the particular bacteria employed so that the resulting vaccines confer passive immunity in addition to the active immunity. The colloid added is preferably a completely soluble proteid such as pseudo-globulin and albumen. In examples, normal blood serum, or immune serum is mixed with bacilli separated from a culture medium or with the whole bouillon culture and placed in the centre compartment of u three-cell electro-osmotic apparatus divided by electrodes and diaphragms, and current is passed for several hours, salt solution being added as required to maintain the conductivity. After the required period the passage of current is continued to eliminate the electrolyte and to cause the separation of euglobulin. The clear solution to be used as a vaccine is separated from the deposit of euglobulin and insoluble bacteria residue in a centrifugal apparatus. In some cases the separated deposit is dissolved in water containing electrolytes and feebly alkaline, and is diluted to form a vaccine to be used alone or mixed with the original clear solution. The bacteria specified are those of swine erysipelas and chicken cholera, and streptococci, pneumococci, and meningococci.
GB24351/20A 1919-08-23 1920-08-21 Manufacture of specific vaccines Expired GB150334A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE150328X 1919-08-23
DE150334X 1919-08-23

Publications (1)

Publication Number Publication Date
GB150334A true GB150334A (en) 1921-06-30

Family

ID=25752455

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24351/20A Expired GB150334A (en) 1919-08-23 1920-08-21 Manufacture of specific vaccines

Country Status (1)

Country Link
GB (1) GB150334A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009493A1 (en) * 1968-05-28 1970-02-06 Merieux Inst
FR2051484A1 (en) * 1969-05-22 1971-04-09 Pilet Charles Non agglutinogenic vaccines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009493A1 (en) * 1968-05-28 1970-02-06 Merieux Inst
FR2051484A1 (en) * 1969-05-22 1971-04-09 Pilet Charles Non agglutinogenic vaccines

Similar Documents

Publication Publication Date Title
GP Immunity to anthrax: protective antigen present in cell-free culture filtrates.
US2961382A (en) Urokinase-a plasmiogen activator and methods of obtaining the same
James Molecular aspects of biological surfaces
Hanahan et al. Biochemical variability of human erythrocyte membrane preparations, as demonstrated by sodium-potassium-magnesium and calcium adenosinetriphosphatase activities
Zotterman et al. Has water a specific taste?
GB150334A (en) Manufacture of specific vaccines
Schechtman Ontogeny of the blood and related antigens and their significance for the theory of differentiation
De Boer et al. Formation of polynucleate avian erythrocytes by polylysine and phospholipase C
Watson et al. The cilia of Tetrahymena pyriformis: Fractionation of isolated cilia
Evans Haemoglobin electrophoresis on cellulose acetate using whole blood samples.
Dreyer Some new principles in bacterial immunity; their experimental foundation, and their application to the treatment of refractory infections
Bisset Natural antibodies in the blood serum of fresh-water fish
Jensen et al. Submicroscopic particles in normal bovine and human milks: A preliminary morphological survey
Olitzki Electric charge of bacterial antigens
McArthur et al. Antigenic mimicry of eel tissues by a myxosporidian parasite?
US3876764A (en) Vaccines for infectious pustular vulvovaginitis
Kazuya et al. Possible identity between the hepatoma alkaline phosphatase and an isozyme of human amniotic membrane (FL cells)
GB505752A (en) Improved process and apparatus for purifying, separating and concentrating colloidaldispersions
Gutfreund An improved method for the fractionation of protein mixtures by electrophoresis
Lynch Blastocystis species in culture: a preliminary communication
Neill STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES: V. PRODUCTION OF ANTIHEMOTOXIN BY IMMUNIZATION WITH OXIDIZED PNEUMOCOCCUS HEMOTOXIN.
Harris The isoelectric point of silk
Sanderson A note on the bacteriophage with respect to complement fixation tests
Bergey Factors determining the Coagulation of Blood Serum by Bacteria
Hindle et al. A soluble specific substance in spirochaetes